223 related articles for article (PubMed ID: 30446159)
1. A Novel Transgenic Rat Model of Robust Cerebral Microvascular Amyloid with Prominent Vasculopathy.
Davis J; Xu F; Hatfield J; Lee H; Hoos MD; Popescu D; Crooks E; Kim R; Smith SO; Robinson JK; Benveniste H; Van Nostrand WE
Am J Pathol; 2018 Dec; 188(12):2877-2889. PubMed ID: 30446159
[TBL] [Abstract][Full Text] [Related]
2. Robust neuroinflammation and perivascular pathology in rTg-DI rats, a novel model of microvascular cerebral amyloid angiopathy.
Zhu X; Hatfield J; Sullivan JK; Xu F; Van Nostrand WE
J Neuroinflammation; 2020 Mar; 17(1):78. PubMed ID: 32127016
[TBL] [Abstract][Full Text] [Related]
3. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Cognitive Decline in a Novel Rodent Model of Cerebral Amyloid Angiopathy Type-1.
Popescu DL; Van Nostrand WE; Robinson JK
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231123
[TBL] [Abstract][Full Text] [Related]
5. rTg-D: A novel transgenic rat model of cerebral amyloid angiopathy Type-2.
Davis J; Xu F; Zhu X; Van Nostrand WE
Cereb Circ Cogn Behav; 2022; 3():100133. PubMed ID: 36324401
[TBL] [Abstract][Full Text] [Related]
6. Distinct Brain Proteomic Signatures in Cerebral Small Vessel Disease Rat Models of Hypertension and Cerebral Amyloid Angiopathy.
Schrader JM; Stanisavljevic A; Xu F; Van Nostrand WE
J Neuropathol Exp Neurol; 2022 Aug; 81(9):731-745. PubMed ID: 35856898
[TBL] [Abstract][Full Text] [Related]
7. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.
Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE
J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504
[TBL] [Abstract][Full Text] [Related]
8. Distinct brain regional proteome changes in the rTg-DI rat model of cerebral amyloid angiopathy.
Schrader JM; Xu F; Van Nostrand WE
J Neurochem; 2021 Oct; 159(2):273-291. PubMed ID: 34218440
[TBL] [Abstract][Full Text] [Related]
9. Impact of Non-pharmacological Chronic Hypertension on a Transgenic Rat Model of Cerebral Amyloid Angiopathy.
Stanisavljevic A; Schrader JM; Zhu X; Mattar JM; Hanks A; Xu F; Majchrzak M; Robinson JK; Van Nostrand WE
Front Neurosci; 2022; 16():811371. PubMed ID: 35368255
[TBL] [Abstract][Full Text] [Related]
10. Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice.
Xu F; Grande AM; Robinson JK; Previti ML; Vasek M; Davis J; Van Nostrand WE
Neuroscience; 2007 Apr; 146(1):98-107. PubMed ID: 17331655
[TBL] [Abstract][Full Text] [Related]
11. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
[TBL] [Abstract][Full Text] [Related]
12. Deficient cerebral clearance of vasculotropic mutant Dutch/Iowa Double A beta in human A betaPP transgenic mice.
Davis J; Xu F; Miao J; Previti ML; Romanov G; Ziegler K; Van Nostrand WE
Neurobiol Aging; 2006 Jul; 27(7):946-54. PubMed ID: 16105708
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Copper Chelation Therapy in a Transgenic Rat Model of Cerebral Amyloid Angiopathy.
Ambi A; Stanisavljevic A; Victor TW; Lowery AW; Davis J; Van Nostrand WE; Miller LM
ACS Chem Neurosci; 2023 Feb; 14(3):378-388. PubMed ID: 36651175
[TBL] [Abstract][Full Text] [Related]
14. Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy.
Lee H; Xu F; Liu X; Koundal S; Zhu X; Davis J; Yanez D; Schrader J; Stanisavljevic A; Rothman DL; Wardlaw J; Van Nostrand WE; Benveniste H
J Cereb Blood Flow Metab; 2021 May; 41(5):1103-1118. PubMed ID: 32791876
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice.
Fryer JD; Taylor JW; DeMattos RB; Bales KR; Paul SM; Parsadanian M; Holtzman DM
J Neurosci; 2003 Aug; 23(21):7889-96. PubMed ID: 12944519
[TBL] [Abstract][Full Text] [Related]
16. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal markers of cerebral amyloid angiopathy and related inflammation in rTg-DI rats.
Schrader JM; Xu F; Agostinucci KJ; DaSilva NA; Van Nostrand WE
Sci Rep; 2024 Apr; 14(1):8441. PubMed ID: 38600214
[TBL] [Abstract][Full Text] [Related]
18. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein.
Miao J; Xu F; Davis J; Otte-Höller I; Verbeek MM; Van Nostrand WE
Am J Pathol; 2005 Aug; 167(2):505-15. PubMed ID: 16049335
[TBL] [Abstract][Full Text] [Related]
19. Human apolipoprotein E2 promotes parenchymal amyloid deposition and neuronal loss in vasculotropic mutant amyloid-β protein Tg-SwDI mice.
Xu F; Vitek MP; Colton CA; Previti ML; Davis J; Van Nostrand WE
J Alzheimers Dis; 2012; 31(2):359-69. PubMed ID: 22635103
[TBL] [Abstract][Full Text] [Related]
20. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy.
Robison LS; Popescu DL; Anderson ME; Francis N; Hatfield J; Sullivan JK; Beigelman SI; Xu F; Anderson BJ; Van Nostrand WE; Robinson JK
J Neuroinflammation; 2019 Jul; 16(1):144. PubMed ID: 31296239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
